Click Here to return To Results

 

Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS Neurol 62:282-284,168, Saiz,A.,et al, 2004 See this aricle in Pubmed Article Abstract The authors report the outcome of 14 patients with severe multiple sclerosis treated with autologous hematopoietic stem cell transplantation (AHSCT) after a median follow-up period of 3 years. The 3-year actuarial probability of progression-free survival was 85.7% and that of disease activity-free survival was 46.4%. On MRI, no T1-enhanced lesions were detected after AHSCT. The mean change in T2 lesion volume from baseline to the third year was û20.2% and that of the corpus callosum area was û12.7%; 50% of this reduction was seen during the first year.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction bone marrow transplantation chemotherapy,CNS treatment and complications with mortality MRI MRI,abnormal multiple sclerosis multiple sclerosis,treatment of prognosis stem cell transplantation treatment of neurologic disorder

Click Here to return To Results